Factors Affecting Protein-Drug Binding: Protein-Related Factors

Albumin is the most abundant protein in plasma, making it the primary drug-binding component. Its high concentration and numerous binding sites give it exceptional capacity to bind diverse drugs. This abundance and accessibility make albumin the dominant protein for drug-protein interactions in the body.

Lipophilic drugs dissolve in the lipid cores of lipoproteins and adipose tissue due to their fat-soluble nature. These substances bind lipophilic drugs by incorporating them into their lipid environment, influenced by physiological pH. This interaction affects drug distribution and availability throughout the body.

Proteins with multiple binding sites can bind larger quantities of drugs simultaneously. Albumin contains numerous binding sites, allowing drugs like ketoprofen, flurbiprofen, and tamoxifen to bind at different locations. Indomethacin, for example, binds to three distinct sites on albumin, enabling multi-site binding that impacts drug distribution and elimination.

Disease states can alter the availability of proteins and tissue components available for drug binding. Changes in protein concentration or composition during illness modify how drugs bind and distribute throughout the body. This altered binding capacity can significantly affect drug distribution and elimination pathways.

α1-acid glycoprotein has limited binding capacity due to its low plasma concentration and smaller molecular size relative to albumin. These characteristics restrict the number of drugs it can bind and reduce its role in drug-protein interactions. Albumin remains the primary protein for most drug-binding processes in the body.

Physicochemical properties of proteins, influenced by physiological pH, significantly determine their ability to bind drugs. These properties affect how proteins interact with different drug molecules and their binding affinity. Understanding these properties is essential for predicting drug behavior and designing therapeutic agents.

Protein concentration is a key determinant of drug-binding capacity in plasma. Higher protein concentrations increase available binding sites and overall drug-binding potential. Since albumin exists in high abundance, it predominantly determines total drug-binding capacity and influences drug distribution throughout the body.